Cornelia de Lange syndrome (CdLS) is characterized by craniofacial dysmorphisms, intellectual disabilities, growth retardation, and several other systemic abnormalities. CdLS is caused by heterozygous germline mutations in structural and regulatory components of cohesin. Mutations in NIPBL, which encodes regulatory subunit of cohesin, are frequently found in individuals with CdLS. CdLS is associated with a currently unknown mechanism of global transcriptional dysregulation. In this study, NIPBL mutants were generated using the CRISPR/Cas9 system to study this mechanism. Clones with a biallelic frameshift mutation in exon 3 of NIPBL, resulting in a truncated N-terminus, displayed transcriptional dysregulation without sister chromatid separation defects. Detailed transcriptome analysis revealed the overexpression of genes in NIPBL mutants that are typically expressed at low levels in wild type and the reduced expression of genes that are typically expressed at high levels in wild type. This result suggested that NIPBL plays a role in fine-tuning gene expression levels. MAU2 protein, that closely interacts with NIPBL, was nearly absent in these clones. The reduction of MAU2 observed in NIPBL mutants points to the importance of the NIPBL N-terminus/MAU2 interaction in transcriptional regulatory role of NIPBL.
INTRODUCTION
Cornelia de Lange syndrome (CdLS) is a multisystem developmental disorder characterized by facial dysmorphisms, short stature, congenital heart disease, limb defects and intellectual disability (1) . CdLS is caused by genetic mutations in cohesin regulatory molecules and cohesin structural components encoded by genes including NIPBL, HDAC8, SMC1A, and SMC3 (2-6). The cohesin complex functions in multiple biological processes including regulation of sister chromatid separation (SCS), DNA repair, DNA looping, and regulation of gene expression (7) . The cohesin complex is made up of the structural proteins SMC1A, SMC3, RAD21 and STAG1/2 and forms a ring-like structure around DNA. NIPBL (Nibbed-B-like protein) forms a heterodimer with MAU2. The NIPBL-MAU2 heterodimer plays an important role in the loading of the cohesin complex onto DNA (8, 9) . Another protein, HDAC8, controls the release of the cohesin complex from DNA (6) . Among the genes implicated in CdLS, mutations are most frequently identified in NIPBL (10) .
The cohesin complex was originally identified by its ability to prevent premature SCS during mitosis, but SCS defects were not observed in cells derived from CdLS probands (11, 12) .
Transcriptome analysis of CdLS probands revealed unique transcriptome signatures, suggesting that the molecular mechanism leading to the CdLS phenotype is caused by transcriptional dysregulation (13, 14) .
We used the CRSIPR/Cas9 system to introduce NIPBL mutations into the cell lines 293FT and HCT116 and evaluated any changes in cellular phenotypes (15) . Previously, how the cohesin complex executes the multiple biological functions such as sister chromatid cohesion and transcriptional regulation, were unknown. In this study, observations of the NIPBL genome-edited lines showed that the N-terminus of NIPBL has a transcriptional regulatory function. Furthermore, the detailed transcriptome analysis revealed that NIPBL is involved in fine-tuning gene expression levels. Genomic DNA was extracted using the NucleoSpin tissue kit (Macherey-Nagel, Duren, Germany) and sequenced by Sanger sequencing. Primers for NIPBL exons 3 and 10 are available upon request. PCR products, pMD20 vector, and NEB10 beta competent cells were used to characterize the 293FT ex10mut mutant cell line by TA cloning.
MATERIALS AND METHODS

Cell culture and genome editing
Western blotting
SDS sample buffer was added to transfected cells to obtain total cellular lysates, which were purified by chromatin fractionation (14) . Obtained lysates were loaded onto Mini-PROTEAN TGX Precast gels (product #456-1086, Bio-Rad, Hercules, CA) and transferred onto a nitrocellulose membrane for western blotting. Antibodies were directed against the Antibody to α -tubulin were (T6074) from Sigma-Aldrich. Two biologically independent replicates were performed.
Giemsa staining and nuclear area measurements
Nocodazole (100 ng/ml; Calbiochem, Merck Millipore, Darmstadt, Germany) was used to treat 293FT and HCT116 cells for 3 h. Treated cells were allowed to swell in a hypotonic solution of dilute phosphate-buffered saline for 5 min at room temperature and then fixed with 
Fluorescence-activated cell sorting
Ethanol, followed by a phosphate-buffered saline wash, was used to fix cells. DNA was stained with a propidium iodine solution, and DNA profiles were evaluated using fluorescence-activated cell sorting with a FACSCalibur flow cytometer and Cell Quest software (BD Biosciences, San Jose, CA).
RNA sequencing
Total RNA was extracted by TRIzol (Life Technologies, Carlsbad, CA) and NucleoSpin RNA (Macherey-Nagel, Duren, Germany). All samples were sequenced on the Illumina HiSeq 2500 platform as single-end 50-bp reads and mapped to the human genome (UCSC build hg19).
Sequencing and mapping statistics are summarized in Supplementary Table S1 . The RNA sequencing analysis (RNA-seq) was performed with TopHat and Cufflinks (17, 18) . Only the protein-coding genes were considered for the transcriptome analysis, and gene-level expression values were estimated by reads per kilobase of exon per million fragments mapped (RPKM) score. Translational start sites prediction was performed with NetStart 1.0 translation initiation site prediction program (http://www.cbs.dtu.dk/services/NetStart/) (19) .
DRB-Nascent RNA sequencing
Before capturing nascent RNA from 293FT cells, 50 µM 5,6-dichloro-1-β-D-ribofuranosyl benzimidazole (DRB) was added to the culture medium to inhibit transcription for 30 min and align the transcription progress. Afterwards, the medium was replaced with DRB-free medium, and 0.5 mM ethylene uridine was added to the medium with subsequent incubation for 60 min. Total RNA was prepared with TRIzol reagent (Invitrogen). A total of 1 µg of ethylene uridine-labeled RNA was biotinylated with 0.5 mM biotin azide using the Click-iT Nascent RNA Capture kit, in accordance with the manufacturer's instructions (Thermo Fisher Scientific, Waltham, MA).
Biotinylated RNA was precipitated with chilled ethanol and resuspended in Ultra-Pure™ DNase/RNase-free distilled water. The purified biotinylated RNA was mixed with Dynabeads MyOne Streptavidin T1 magnetic beads in Click-iT RNA binding buffer and heated at 70°C for 5 min, followed by incubation at room temperature for 30 min with gentle agitation.
Following washing with Click-iT wash buffer 1 and wash buffer 2, the beads were resuspended in wash buffer 2 and used for cDNA synthesis. cDNA was synthesized using the SuperScript® Izumi et al.
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VILO™ cDNA synthesis kit (Thermo Fisher Scientific) in accordance with the manufacturer's instructions. cDNA was amplified using a slightly modified in vitro transcription amplification method (20) . Second-strand cDNA synthesis was used to assemble a library and sequenced following the manufacturer's instructions (NEB Next DNA Library Prep Master Mix Set for Illumina; NEB E6040L). Sequenced reads were aligned to the human reference genome hg19 using TopHat v2.1.0 with the '--no-coverage-search --read-realign-edit-dist 0' option selected (17) . Averaged nascent DNA strand profiles were calculated and visualized using custom scripts written in Python and R. Information and statistics regarding sequenced reads and mapping rates are summarized in the Supplementary Table S1 .
ChIP-seq
Both 293FT wild-type (WT) and NIPBL genome-edited cell line clones were used for ChIP-seq (chromatin immunoprecipitation followed by massively parallel sequencing) (6,14) with a custom-made antibody against RAD21 (6, 14) . Harvested input and ChIP DNA samples were sequenced by the Illumina HiSeq 2500 Sequencing System (San Diego, CA). Sequenced reads were aligned to the human reference genome hg19 using Bowtie software set to allow two mismatches in the first 28 bases per read and output only uniquely mapped reads (-n2 -m1 option). Mapping statistics are summarized in Supplementary Table S3 . DROMPA v2.5.3
software was used for ChIP-seq and visualization (21) . To facilitate comparison of detected peaks between ChIP experiments, the number of mapped reads per cycle was normalized to the total number of mapped reads. The average reads plot around a transcription start site (TSS) was obtained using the PROFILE command, and RefSeq gene annotation was obtained from the UCSC genome browser (http://genome.ucsc.edu/).
RESULTS
CRISPR genome editing of the NIPBL locus
The presence of a haploinsufficient NIPBL with frameshift mutations in exons 3 and 10 has been observed in patients with CdLS (21) . gRNAs targeting exons 3 and 10 were designed to model genetic alterations seen in patients with CdLS ( Figure 1A ). Exon 10, encoding a coiled-coil region and an undecapeptide repeat, is a CdLS mutation hotspot (10). We introduced NIPBL mutations into two commonly used human cell lines, 293FT and HCT116.
Mutations were introduced via transfection of Cas9 and gRNA plasmids into cells, and single-cell cloning was performed using the limiting dilution technique. The presence of NIPBL mutations was confirmed by Sanger sequencing. Figure S1E and S1F). The clones described above were isolated and used for all subsequent experiments ( Table 1) .
Consequences of NIPBL mutations
To evaluate the effect of frameshift mutations in NIPBL, we performed western blotting using NIPBL antibodies in CRISPR genome-edited cell lines. Three different NIPBL antibodies were used, including one that recognizes the NIPBL N-terminus (amino acid residues 1-300; sc-374625), one that recognizes the protein-coding region of exon 10 (A301-779A), and one that recognizes the C-terminus of NIPBL short form (isoform B; AM20797 KT55). Western 
Effects of NIPBL deletions on cohesin and loader complexes
To evaluate the effect of the absence of full-length NIPBL, we performed western blotting with MAU2 and SMC1A antibodies following chromatin fraction separation of cell lines 293FT and HCT116. Surprisingly, the quantity of MAU2 in 293FT cell clone ex3mut and HCT116 cell clone ex3mut1 was markedly diminished in both the total cellular fraction and the chromatin fraction ( Figure 1D and Supplementary Figure 1D) . However, the amount of SMC1A was only slightly reduced in these cell-line clones. In 293FT clone ex10mut and HCT116 clones ex3mut2 and ex10mut1, the amount of MAU2 was slightly decreased in the total cellular lysate and decreased in the chromatin fraction ( Figure 1D and Supplementary Figure S1D ). RNA-seq revealed that MAU2 expression was comparable between the control (10.9 RPKM) and 293FT
clone ex3mut (12.9 RPKM); therefore, the reduction of MAU2 was likely not due to reduced gene expression.
Effect on SCS
Because NIPBL is a cohesin loading factor and the main function of the cohesin complex is to maintain sister chromatid cohesion, the effect of NIPBL mutations on SCS was
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evaluated. The observed frequency of the SCS defects was very low in both 293FT cell clone ex3mut and HCT116 clone ex3mut1. The frequency of SCS defects in these clones was comparable to that of WT 293FT and HCT116 cells (Table 2 and Figure 2A ). Normal SCS defect frequency was observed in the remaining HCT116 clones, including ex3mut2 and ex10mut1.
However, the frequency of SCS defects was higher in 293FT clone ex10mut, which had a reduced amount of full-length NIPBL, including an increased amount of the NIPBL isoform lacking exon 10. This result suggested that reducing the amount of NIPBL (inclusive of residues encoded by exon 10) may have a major effect on the frequency of SCS defects.
Effect on nuclear area
Cohesin plays an important role in organizing nucleosome architecture. In cohesin component mutants of CdLS cell lines, chromatin decompaction has been observed (24).
Evaluation of nuclear area in NIPBL CRISPR genome-edited cell lines revealed no major difference from WT in the nuclear area of 293FT clone ex3mut, but the nucleus was slightly larger in 293FT clone ex10mut ( Figure 2B ). Analysis of cell cycle distribution by fluorescence-activated cell sorting showed no major difference among WT 293FT cells and clones ex3mut and ex10mut (Supplementary Figure S5) .
Transcriptome analysis
We next evaluated the transcriptomic effects of NIPBL frameshift mutations. RNA-seq of WT 293FT cells and clones ex3mut and ex10mut revealed that both clones had similar transcriptome alteration compared to WT (Supplementary Table S1 and Figure 3 Table S2 ).
To further characterize transcriptome alterations resulting from mutations in NIPBL, DRB-nascent RNA-seq was performed, in duplicate, on WT 293FT cells and clone ex3mut.
DRB-nascent RNA-seq is a method to quantify the amount of newly transcribed mRNA molecules within a certain period (25). The results showed a correlation of global gene transcription patterns and gene expression levels between total RNA-seq and DRB-nascent RNA-seq (R-value: 0.30; Supplementary Figure S6 ). Global DRB-nascent RNA-seq profile patterns were similar between WT and ex3mut clone replicates ( Figure 4A ). DRB-nascent RNA-seq profiles of differentially expressed genes in ex3mut showed no major differences in downregulated genes. Only the reduction of nascent RNA from the latter half of the gene coding region was observed ( Figure 4C ). Differences between WT and ex3mut were more apparent in ex3mut upregulated genes; increased amounts of nascent RNA transcript were seen for the entire coding region ( Figure 4B ).
The DRB-nascent RNA-seq profile was distinctively different between ex3mut upregulated and downregulated genes. In ex3mut upregulated genes, there were no peaks around the TSS; for ex3mut downregulated genes, however, there were peaks around the TSS, which may represent nascent RNA produced from paused RNA polymerase II (Figure 4 ).
Furthermore, comparison of nascent RNA-seq profiles between upregulated and downregulated genes indicated that expression of the downregulated genes is higher than that of the upregulated genes, suggesting that the effect of NIPBL deficiency is distinctively different for genes that are normally expressed at high levels compared with those expressed at low levels ( Figure 5A ). A similar trend was seen in HCT116 cell mutant ex3mut1 ( Figure 5B ). These observations prompted us to re-evaluate the RNA-seq results for a CdLS skin fibroblast sample, and indeed the gene expression pattern was similar to that observed in ex3mut mutants (14) ( Figure 5C ) These findings indicated that gene expression patterns are less fine-tuned in cells with NIPBL mutations.
RAD21 ChIP-seq
ChIP-seq with RAD21 antibody was carried out on WT 293FT cells and clones ex3mut and ex10mut to evaluate the genome-wide distribution of cohesin (Supplementary Table   S3 ). RAD21 is a component of the cohesin complex. The number of identified RAD21 binding sites was comparable among the three 293FT lines (Table 3 ). The most notable difference was in peak number located upstream of genes; a ~10% reduction in peak number was observed in both clones ex3mut and ex10mut compared with WT.
TSS profile analysis was performed to further evaluate genome-wide alterations in the distribution of RAD21. The results revealed a reduction in TSS peaks in both clones ex3mut and ex10mut. These data were consistent with the observed reduction in gene upstream peak number ( Figure 6A ). TSS profile analysis of differentially expressed genes showed a similar reduction in RAD21 binding in both upregulated and downregulated genes ( Figure 6B and 6C).
DISCUSSION
Cohesin and its loader complex have various roles in multiple biological processes, but how they carry out these roles remains unknown. Previous studies have revealed that cohesin loaders are essential for embryogenesis because NIPBL or MAU2 null mice could not be obtained (26). NIPBL genome-edited cell lines provided a unique opportunity to evaluate the effect of the complete elimination of full-length NIPBL. Our observations indicate that full-length NIPBL is not essential for cell viability and that an N-terminally truncated NIPBL can compensate for the lack of full-length NIPBL. Based on observations of shared transcriptome alterations between NIPBL exon 3-targeted and exon 10-targeted clones and the absence of a SCS defect phenotype in the exon 3-targeted clone, we concluded that the N-terminus of NIPBL is mainly required for transcriptional regulation and is not necessary for the control of sister chromatid cohesion or nuclear compaction. To our knowledge, this is the first report of the functional dissection of NIPBL.
In CdLS patients, frameshift mutations in NIPBL exon 3 have been reported (27) that are similar to those we detected in 293FT clone ex3mut. We demonstrated that this mutation does not affect SCS. Therefore, abnormal SCS is unlikely to be the underlying disease mechanism of CdLS; rather, our data suggest that CdLS is a disorder of transcriptional regulation (28). Clone ex3mut lacks the N-terminal region of NIPBL, and the amount of truncated NIPBL was reduced; Hence, the ex3mut cells were able to tolerate a moderate reduction of NIPBL and retain normal SCS. This observation is consistent with the absence of SCS defects detected in CdLS (11, 12) . Furthermore, it is unlikely that MAU2 plays a role in SCS, i.e., given the absence of MAU2 in clone ex3mut and HCT116 clone ex3mut1.
Because CdLS is caused by various mutations in NIPBL, including whole-gene deletion, haploinsufficiency of NIPBL represents the underlying genetic mechanism of CdLS.
Although a reduction of truncated NIPBL was observed in 293FT clone ex3mut compared with WT, the amount of truncated NIPBL in HCT116 clone ex3mut1 was comparable to WT. However, Further studies are warranted to deepen our understanding of the transcriptional regulation mechanisms of the NIPBL-MAU2 heterodimer.
We did not observe a correlation between altered RAD21 genome-wide binding and transcriptional changes. Because reduced binding of RAD21 was a genome-wide phenomenon, expression abnormalities may have been triggered in genes predisposed for transcriptional alteration. We found that gene expression level may serve as such a predisposing factor. More specifically, genes with low WT expression levels tended to be overexpressed upon NIPBL inactivation both in NIPBL genome-edited cell lines and CdLS samples. We previously demonstrated the association between the degree of altered RNA polymerase II distribution and gene expression alterations, as well as the involvement RNA polymerase II pausing/elongation abnormalities, in CdLS (14) . Therefore, the effect of transcriptional pausing/elongation defects may differ between downregulated and upregulated genes.
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